Prospect Capital (PSEC) Tops Q2 EPS by 3c

Prospect Capital (NASDAQ: PSEC) reported Q2 EPS of $0.28, $0.03 better than the analyst estimate of $0.25.

For earnings history and earnings-related data on Prospect Capital (PSEC) click here.

You May Also Be Interested In

• Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial
• EMA validates Pfizer and Valneva's Lyme disease vaccine application
• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral